Regeneron's CEO is hopeful he can bargain with pharmacy benefit managers to lower the cost of its cholesterol drug for patients.
Sage Therapeutics has to balance two competing interests when pricing its postpartum depression drug, CEO Jeff Jonas says.
Amazon can reinvent the parts of the health-care system, but it needs to be careful with patient data.
Is there a way "to go directly to the patient with some of these answers and some of these products?" John Noseworthy asks.
Over-the-counter status would give the FDA more tools to look at the safety and benefits of e-cigarettes.
Find out what's next at the FDA when CNBC's Meg Tirrell speaks with commissioner Gottlieb at Healthy Returns.
Craig Venter, the geneticist who mapped the human genome in 2000, believes he can help people live to 100, maybe beyond.
Big pharma is rushing to close its innovation gap by investing in start-ups that can help them develop new drugs.
Luke Dow is an assistant professor of biochemistry at Weill Cornell Medicine.
The FDA will soon take steps aimed at curbing e-cigarette use among younger people, FDA chief Dr. Scott Gottlieb says.
CVS Health shattered expectations when it would acquire Aetna in a $69 billion deal.
The Berkshire Hathaway-Amazon-JP Morgan health-care alliance will disappoint if it does no more than focus on costs.
Political forces are working against the urgent need to step up breakthroughs for diseases like Alzheimer's and cancer.
The company has joined Microsoft and others in a bid to globalize a U.S. invention.
Former Celgene CEO Bob Hugin is running for Senate in New Jersey. Here's how he says we need to fix health care.
Vertex plans to start phase 3 clinical trials of compounds called VX-659 and VX-445 as part of combination regimens.
The reasons behind the soaring cost of health care in the US that insurance companies don't want you to know about.
CNBC presents a one-day event at NYC’s Roosevelt Hotel that brings together top health care investors, CEOs and technologists to explore the innovations that will drive better outcomes, financially and clinically.
Every health care company seeks to scale the best technology and develop profitable ways to cover the massive cost of research and development, investors are looking for actionable intelligence on who’s breaking through, and patients are hungry for affordable and effective care. Healthy Returns is a convening of leaders who are improving patient outcomes, maximizing innovation, building great new companies and reinventing incumbents.
Led by CNBC’s anchors and reporters and with input from a world-class advisory board, Healthy Returns will hone in on groundbreaking ideas that will transform the health care industry, cutting through the noise and weeding out the "sales pitch."
The Roosevelt Hotel
45 E 45th Street
New York, NY 10017
To reserve a room, please call the Roosevelt Hotel directly at 212-661-9600.
Are you looking for more information? Please contact the following:
•For sponsorship opportunities, contact Alisha Hathaway
•For speaker and editorial inquiries, contact Maneet Ahuja
•For press and media inquiries, contact Jennifer Dauble
•For other questions, contact firstname.lastname@example.org